GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (FRA:BA3) » Definitions » Price-to-Owner-Earnings

Azenta (FRA:BA3) Price-to-Owner-Earnings : (As of Jan. 18, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Azenta Price-to-Owner-Earnings?

As of today (2025-01-18), Azenta's share price is €51.00. Azenta does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Azenta's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Azenta was 157.87. The lowest was 1.39. And the median was 36.53.


FRA:BA3's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.52
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-01-18), Azenta's share price is €51.00. Azenta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-2.73. Therefore, Azenta's PE Ratio (TTM) for today is At Loss.

As of today (2025-01-18), Azenta's share price is €51.00. Azenta's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.07. Therefore, Azenta's PE Ratio without NRI for today is At Loss.

During the past 13 years, Azenta's highest PE Ratio without NRI was 2997.56. The lowest was 0.00. And the median was 74.03.


Azenta Price-to-Owner-Earnings Historical Data

The historical data trend for Azenta's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Price-to-Owner-Earnings Chart

Azenta Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.86 91.33 1.53 - -

Azenta Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 152.56 - - -

Competitive Comparison of Azenta's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Azenta's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Azenta's Price-to-Owner-Earnings falls into.



Azenta Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Azenta's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=51.00/-2.62
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Azenta  (FRA:BA3) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Azenta Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Azenta's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Azenta Business Description

Traded in Other Exchanges
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Azenta Headlines

No Headlines